Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuli Yang

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
JAMA Oncology|July 31, 2025
Tibremciclib or Placebo Plus Fulvestrant in Hormone Receptor-Positive and ERBB2-Negative Advanced Breast Cancer After Endocrine Therapy: A Randomized Clinical TrialZhonghua Tao, Jian Zhang, Qiufan Zheng, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Pathological Tau transmission initiated by binding lymphocyte-activation gene 3Chan Chen, Ramhari Kumbhar, Hu Wang, et al.
Molecular Cancer|June 11, 2025
Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trialXiangrui Meng, Xiuli Yang, Yonggui Hong, et al.
Science (New York, N.Y.)|January 12, 2023
Dome1-JAK-STAT signaling between parasite and host integrates vector immunity and developmentVipin S Rana, Chrysoula Kitsou, Shraboni Dutta, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2024
Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron TransmissionChan Chen, Ramhari Kumbhar, Hu Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2025
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trialChunmei Bai, Yi Zheng, Meili Sun, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
JAMA Oncology|July 31, 2025
Tibremciclib or Placebo Plus Fulvestrant in Hormone Receptor-Positive and ERBB2-Negative Advanced Breast Cancer After Endocrine Therapy: A Randomized Clinical TrialZhonghua Tao, Jian Zhang, Qiufan Zheng, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Pathological Tau transmission initiated by binding lymphocyte-activation gene 3Chan Chen, Ramhari Kumbhar, Hu Wang, et al.
Molecular Cancer|June 11, 2025
Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trialXiangrui Meng, Xiuli Yang, Yonggui Hong, et al.
Science (New York, N.Y.)|January 12, 2023
Dome1-JAK-STAT signaling between parasite and host integrates vector immunity and developmentVipin S Rana, Chrysoula Kitsou, Shraboni Dutta, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2024
Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron TransmissionChan Chen, Ramhari Kumbhar, Hu Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2025
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trialChunmei Bai, Yi Zheng, Meili Sun, et al.
Pageof 21